<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>M. Rajput);</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Leveraging Machine Learning to Uncover the Relationship between Diabetes and Alzheimer's Disease Progression</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Harsh Dev Singh</string-name>
          <email>hdevsingh222@gmail.com</email>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Mannat Rajput</string-name>
          <email>mannatrajput2411@gmail.com</email>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Dr. Alankrita Aggarwal</string-name>
          <email>Alankrita.agg@gmail.com</email>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>AIT-CSE Chandigarh University</institution>
          ,
          <addr-line>Mohali</addr-line>
          ,
          <country country="IN">India</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>CMIS-2025: Eighth International Workshop on Computer Modeling and Intelligent Systems</institution>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>Chandigarh University</institution>
          ,
          <addr-line>Mohali</addr-line>
          ,
          <country country="IN">India</country>
        </aff>
      </contrib-group>
      <pub-date>
        <year>2025</year>
      </pub-date>
      <volume>000</volume>
      <fpage>0</fpage>
      <lpage>0002</lpage>
      <abstract>
        <p>Diabetes Mellitus is a metabolic complex and chronic non-communicable disorder affecting a large population in the world. Different studies have shown the damage caused by Diabetes Mellitus on multiple systems, which leads to complications such as cancer, cardiovascular disorders, and sarcopenia. The changes in insulin, glycaemia, or glucose levels bring multiple changes in the body, including the formation of oxidative species, inflammation, Advanced Glycation End (AGE) products, and hormonal imbalance. In recent times, more attention has been given to the association of Diabetes and cognitive dysfunction because of its increasing prevalence and the severe impact on the lives of diabetic patients. Moreover, the part of different proteins and pathways related to Diabetes that lead to the occurrence of other diseases has been demonstrated. This research presents a predictive model for the early detection of diabetes-associated cognitive diseases using machine learning techniques. The model utilizes patient health records, lifestyle factors, and diabetes progression data to predict cognitive decline risks. The dataset is pre-processed using statistical analysis, followed by feature selection techniques to optimize the model's performance. Various machine learning algorithms, including decision trees, random forests, and neural networks, are explored to determine the most accurate approach for predictive analysis. The study demonstrates that early detection models can effectively predict diabetes-associated cognitive decline (DACD) onset with high precision, offering a valuable tool for healthcare providers. The results show that predictive models can support timely interventions and personalized treatment plans for at-risk patients.</p>
      </abstract>
      <kwd-group>
        <kwd>eol&gt;Diabetes Mellitus</kwd>
        <kwd>Cognitive Dysfunction</kwd>
        <kwd>Alzheimer's Disease</kwd>
        <kwd>Dementia</kwd>
        <kwd>Cognitive Learning</kwd>
        <kwd>Machine Learning</kwd>
        <kwd>Predictive Modeling</kwd>
        <kwd>Explainable AI (XAI)</kwd>
        <kwd>Neural Networks</kwd>
        <kwd>Deep Learning</kwd>
        <kwd>Healthcare AI</kwd>
        <kwd>Chronic Disease Prediction</kwd>
        <kwd>1Dementia Prediction</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>1. Introduction</title>
      <p>for this disorder has been clearing the amyloid β and τ proteins, although no exact treatment is
available.</p>
      <p>
        The rising prevalence of Diabetes necessitates early detection methods for DACD to mitigate
longterm health implications. Machine learning models offer a promising solution by leveraging data from
diverse sources, including clinical records, lifestyle factors, and medical imaging, to predict the
likelihood of cognitive decline in diabetic patients. This paper proposes a novel predictive model that
integrates multiple data points and advanced machine learning algorithms to provide early detection
of DACD [
        <xref ref-type="bibr" rid="ref4">4</xref>
        ].
      </p>
      <sec id="sec-1-1">
        <title>1.1. Co-relation of Diabetes with Cognitive Dysfunction</title>
        <p>
          The first series of cases of association between Cognitive Dysfunction and Diabetes Mellitus was
reported in the year of 1922. Patients who developed Diabetes Mellitus (type 1 or type 2) before the age
of 4 years were found to have impaired executive skills and difficulty concentrating on work. The
predictors of Cognitive Impairment would include the duration of diabetic status (prominence
increases with duration of more than 5 years), increased blood group, hypertension, and age group
above 51. However, since glucose is the primary substrate for brain energy metabolism then, in the
case of Diabetes Mellitus, neurons are unable to store/synthesize glucose, which is initially needed for
the systematic circulation and transportation across the blood-brain barrier [
          <xref ref-type="bibr" rid="ref5">5</xref>
          ]. So, the brain
consumes a large amount of glucose energy, and there is the maximum effect of free radicles, loss of
brain cells, and memory function in the brain's hippocampal region. Moreover, as there is an increase
of Insulin concentration in the body, this boosts the levels of β-amyloid and senile plaque formation,
which leads to Alzheimer's disease. Another aspect would be the increased formation of free radicles
[
          <xref ref-type="bibr" rid="ref6">6</xref>
          ].
        </p>
        <p>
          It is found that with Diabetes, the risk of cognitive dysfunction and dementia is increased by 1.5 and
1.6 times, respectively. As per the study conducted by Satyajeet Roy et al. on cognitive function and
control of type-2 Diabetes Mellitus in adults, it was found that cognitive dysfunction prevalence was
around 65% [
          <xref ref-type="bibr" rid="ref7">7</xref>
          ]. The odds of the development of cognitive dysfunction were 9-fold higher in patients
affected by Diabetes as compared to non-diabetic ones. This dysfunction was higher in the age group
of 51-60. The decreased levels of glycaemic control can occur at any time, regardless of age. These
decreased levels enhance the cognitive dysfunction[60]. Brands et al. demonstrated that the
complications become worse in patients with other diabetic complications along with Diabetes
Mellitus. Patients with type 2 Diabetes Mellitus have reduced psychomotor speed, frontal lobe
functioning, verbal memory, complex motor functioning, processing speed, working memory,
recalling capabilities, visual retention, and attention. Sinclair et al. found that the score on self-care
was lower in patients with mini-mental status. Bruce et al. demonstrated that out of all the older
patients with type 2 diabetes, 15% had depression, and 12% had cognitive dysfunction [
          <xref ref-type="bibr" rid="ref8">8</xref>
          ].
        </p>
        <p>
          The occurrence of Diabetes would include Insulin Resistance, Sub-diabetic hyperglycaemia, and
prediabetic stress. This leads to insulin signalling pathway impairment, subsequently hindering
tyrosine's phosphorylation and Insulin Receptor Substrate (IRS) [
          <xref ref-type="bibr" rid="ref9">9</xref>
          ]. This negatively impacts the
expression and transcription of specific transcription factors, i.e., Nuclear Factor- κ B (NF-κ B), Cyclic
AMP response element binding protein, and Glycogen Synthase Kinase-3 β (GSK-3β). Moreover,
increased levels of Advanced Glycation End Products (AGEs) and reactive oxidative species. These
reactive oxidative species activate polyol and hexosamine pathways, eventually contributing to
Diabetes Associated Cognitive Dysfunction (DACD). Along with this, there is upregulation of CD16
and CD32 due to M1 polarization and increased presentation of Tumor Necrosis Factor (TNF-α),
Interleukin-β (IL-1β), and Interleukin-6 (IL-6) as demonstrated in Figure 2. There are 1.5 times more
chances of showcasing neurodegeneration with Diabetes, making it a global challenge to face. The
accepted clinical symptoms of Diabetes Mellitus would include the loss of strength, polyuria,
polydipsia, loss of vision, pruritus, retrobulbar neuritis, paraesthesia, sexual disorders, abdominal
pain, loss of appetite, hypertension, and polyphagia. Out of these, any one symptom is elicited in 95%
of diabetic patients [
          <xref ref-type="bibr" rid="ref10">10</xref>
          ]. Various evidence has proved that, along with genetic and environmental
factors, other alterations such as insulin resistance, hypoglycaemia, hyperglycaemia, oxidative stress,
hormonal imbalance, age, and hyperphosphorylation [
          <xref ref-type="bibr" rid="ref11">11</xref>
          ].
        </p>
        <p>
          The increasing prevalence of the association of Diabetes with Alzheimer's Disease has brought
many eyes to this and requires primary attention at the initial stages only. Predictive models such as
Random Forest, Support Vector machines (SVM), and Neural Networks will be used to examine
intricate interactions among various clinical and lifestyle factors and their influence on diabetes
complications, primarily cognition-related diseases. Our goal through these advanced techniques is to
improve the early screening of Diabetic Associated Cognitive Dysfunction (DACD), therefore
increasing patient's health/safety and assisting physicians with managing their patients [
          <xref ref-type="bibr" rid="ref12">12</xref>
          ].
        </p>
      </sec>
    </sec>
    <sec id="sec-2">
      <title>2. Related Work</title>
      <p>
        Several studies have focused on the correlation between Diabetes and cognitive decline. Smith et al.
[
        <xref ref-type="bibr" rid="ref13">13</xref>
        ] explored the neurobiological mechanisms linking Diabetes to dementia, emphasizing the role of
glucose metabolism and insulin signalling in the brain. Johnson et al. [14] proposed a predictive model
based on clinical data, focusing on the use of logistic regression to assess cognitive impairment risks in
diabetic patients. Martinez et al. [15] applied deep learning techniques to longitudinal health records
to predict dementia onset in type 2 diabetes patients, reporting an accuracy rate of 85%. ++
      </p>
      <sec id="sec-2-1">
        <title>Title of the Author study (s) Study Design</title>
      </sec>
      <sec id="sec-2-2">
        <title>Populatio Sampl</title>
        <p>n selected e</p>
      </sec>
      <sec id="sec-2-3">
        <title>Main Findings Key outcomes</title>
        <p>Is Diabetes Edward
Associated W.
with Gregg,
Cognitive PhD;
Impairmen Kristine
t and Yaffe,
Cognitive MD; Jane
Decline A.</p>
        <p>Among Cauley,
Older DrPH; et
Women? al
(2000)
Compariso Chi-Hao
n of Liu,
multiple Chung-H
linear sin Peng,
regression Li-Ying
and Huang,
machine Fang-Yu
learning Chen,
methods in Chun-He
predicting ng Kuo,
cognitive Chung-Z
function in e Wu,
older and
Chinese Yu-Fang
type 2 Cheng
diabetes
patients
Prospectiv Communi 9679
e Cohort
tyStudy dwelling
white
women</p>
      </sec>
      <sec id="sec-2-4">
        <title>Size Age Ran ge</title>
        <p>6599
year
s</p>
      </sec>
      <sec id="sec-2-5">
        <title>Test Cohort Study</title>
      </sec>
      <sec id="sec-2-6">
        <title>Older</title>
        <p>T2DM
people
197
60(98 95
male + year
99 s old
female
)</p>
        <p>Thompso
n, A. et
al.</p>
        <p>Li, Z et
al.</p>
      </sec>
      <sec id="sec-2-7">
        <title>Zhang, Y. et al.</title>
      </sec>
      <sec id="sec-2-8">
        <title>Gupta, S. of et al.</title>
      </sec>
      <sec id="sec-2-9">
        <title>Park, J. et</title>
        <p>al.</p>
        <p>Predicting
Cognitive
Decline in
Diabetic
Patients
Using
Machine
Learning</p>
      </sec>
      <sec id="sec-2-10">
        <title>Deep</title>
        <p>Learning
for Early
Detection
of
DiabetesRelated
Dementia
A
Predictive
Model for
DiabetesAssociated
Cognitive
Disorders
Using XG
Boost
Hybrid
Model
Neural
Networks
and
Decision
Trees for
Cognitive
Impairmen
t in
Diabetes
Multimoda
l Data
Integration
for
Predicting
Cognitive
Decline in
Diabetic
Patients
Random
Forest,
Logistic
Regression
, Support
Vector
Machine</p>
      </sec>
      <sec id="sec-2-11">
        <title>Convolutio nal Neural Networks (CNN)</title>
      </sec>
      <sec id="sec-2-12">
        <title>XG Boost</title>
      </sec>
      <sec id="sec-2-13">
        <title>Neural</title>
        <p>Network
and
Decision
Tree
Hybrid</p>
      </sec>
      <sec id="sec-2-14">
        <title>MultiLayer Perceptron (MLP)</title>
      </sec>
      <sec id="sec-2-15">
        <title>Diabetic Patients</title>
      </sec>
      <sec id="sec-2-16">
        <title>Diabetic Patients</title>
      </sec>
      <sec id="sec-2-17">
        <title>Diabetic Patients</title>
      </sec>
      <sec id="sec-2-18">
        <title>Diabetic</title>
        <p>Patients
500
(300 M
/ 200
F)
600
(350 M
/ 250
F)
550
(320
males
and
230
female
s)
550
(250
males
and
230
female
s)
450
(270
males
and
180
female
s)
4575
year
s
4070
year
s
6085
year
s
5580
year
s</p>
        <p>XG Boost Insulin
provided resistance
88% and
accuracy, hypertensio
identifying n were
insulin major
resistance as predictors.
a key factor.</p>
      </sec>
      <sec id="sec-2-19">
        <title>Predicting</title>
        <p>Dementia
in Diabetic
Patients
Using
Explainabl
e AI
Models</p>
      </sec>
      <sec id="sec-2-20">
        <title>Singh, R. Ensemble et al. Learning (AdaBoost)</title>
      </sec>
      <sec id="sec-2-21">
        <title>Diabetic Patients</title>
      </sec>
      <sec id="sec-2-22">
        <title>Kim, S. et Spatioal. Temporal Recurrent Neural</title>
        <p>Networks
(RNN)</p>
      </sec>
      <sec id="sec-2-23">
        <title>Diabetic Patients</title>
      </sec>
      <sec id="sec-2-24">
        <title>Akhtar,</title>
        <p>S. et al.
Random
Forest</p>
      </sec>
      <sec id="sec-2-25">
        <title>Diabetic Patients</title>
      </sec>
      <sec id="sec-2-26">
        <title>Wang, L et al.</title>
      </sec>
      <sec id="sec-2-27">
        <title>Diabetic</title>
        <p>Patients
Gradient
Boosting
with
Explainabl
e AI
520
(300
male
and
220
female
)
600
(330
males
and
270
female
s)
530
(290
males
and
240
female
s)
450
(280
males
and
170
female
s)
500
(290
males
and
210
female
s)
5075
year
s
4580
year
s
5585
year
s
5075
year
s</p>
        <p>While previous research has primarily focused on predictive models for general cognitive decline
or specific conditions like Alzheimer's disease, this paper takes a broader approach by incorporating
various types of DACD into a single predictive framework. Furthermore, our model extends beyond
clinical data by integrating patient lifestyle and behavioural factors to enhance predictive accuracy.</p>
      </sec>
    </sec>
    <sec id="sec-3">
      <title>3. Methodology</title>
      <sec id="sec-3-1">
        <title>3.1. Data Collection and Description</title>
        <p>The datasets utilized in this study were collected from three primary sources: One dataset from Kaggle
(Dataset 1) and the dataset gleaned from a clinical study published in Springer (Dataset 2). The
combined data sets offered complete patient information regarding diabetes progress and cognitive
impairment in patients between 61 and 89 years old. Each dataset includes the following key
attributes, which are essential for predicting the early onset of Diabetes-Associated Cognitive
Diseases (DACD):
 AGE: Ages from 61–89 years in Dataset 1, and 73 ± 6.0 years in Dataset 2.
 GENDER: Data concerning Dataset 1 for both sexes were presented, including 151 males and
169 females.
 ETHNICITY: It includes multivariate populations such as Caucasians, African Americans,</p>
        <p>Asians, and the rest.
 Educational Background: Literacy levels among the respondents ranged from no KR
(kindergarten) to tertiary-level education.
 BMI: The body mass index in the analysis was between 15.6 and 39.1 for Dataset 1 and 25.8 ±
3.9 for Dataset 2.
 LIFESTYLE FACTORS: These are smoking status, alcohol intake, physical activity, and quality
of diet consumed.
 Medical History: Traditional data sources contain patient data in terms of a history of
depression, hypertension, and cardiovascular diseases, as well as a history of diabetes or
cognitive disorders in the family.
</p>
        <p>COGNITIVE DECLINE INDICATORS: Memory complaints, confusion, forgetfulness, and
other behavioural symptoms were noted.</p>
      </sec>
      <sec id="sec-3-2">
        <title>3.2. Symptom Table and Feature Identification</title>
        <p>5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.</p>
        <p>Age (in years)
Gender
Ethnicity</p>
        <sec id="sec-3-2-1">
          <title>Education</title>
          <p>BMI
Smoking
Alcohol Consumption
Physical Activity
Diet Quality
Sleep Quality
Family History
CVD
Depression
Head Injury
Hypertension
Systolic BP
Diastolic BP
Cholesterol Total
Cholesterol LDL
Cholesterol HDL
Cholesterol Triglycerides
Functional Assessment
Memory Complaints
Behavioral Problems
Confusion
Disorientation
Personality Changes
Difficulty completing tasks
Forgetfulness
61-89
M=151, F=169
Caucasian= 191
African American= 72
Asian= 26
Others= 31</p>
          <p>As indicated, the table discusses the significant characteristics used in constructing the model for
DACD. These variables were selected based on what signifies Diabetes self-management and what is
influential to cognitive functioning, as supported by prior literature and empirical findings.</p>
        </sec>
      </sec>
      <sec id="sec-3-3">
        <title>3.3. Data Pre-Processing</title>
      </sec>
      <sec id="sec-3-4">
        <title>3.3.1. Data Cleaning and Imputation:</title>
        <p>So, what exactly do data cleaning and imputation mean? All the missing and incomplete records in the
datasets were dealt with for analysis from the two datasets. Mean scores were assigned when scoring
non-response on continuous variables like BMI, cholesterol, and blood pressure. For nominal variables
such as smoking status and alcohol consumption, the imputations were replaced with the most often
occurring class or mode accordingly.</p>
      </sec>
      <sec id="sec-3-5">
        <title>3.3.2. Outlier Detection:</title>
      </sec>
      <sec id="sec-3-6">
        <title>3.4. Feature Encoding</title>
      </sec>
      <sec id="sec-3-7">
        <title>3.5. Model Development</title>
      </sec>
      <sec id="sec-3-8">
        <title>3.5.1. Model Selection:</title>
        <p>In other words, z-score analysis was used to detect outliers. Outliers were defined as any data points
that were at ±3 or more standard deviations away from the mean, and such values were not included
in the analysis.</p>
      </sec>
      <sec id="sec-3-9">
        <title>3.3.3. Normalization and Standardization:</title>
        <p>Since BMI, cholesterol, systolic blood pressure, and other values are continuous variables, data scaling
was applied using Min-Max Scaling to normalize the range of the measure between 0 and 1. For other
features that needed more uniformity of variability, the z-score normalization was performed with
systolic blood pressure and cholesterol levels standardized within the training data set to have a mean
of 0 and a standard deviation of 1.</p>
        <p>Gender, smoking status, and family history have been categorized into nominal features, which were
encoded to numerical values using the One Hot Encoding method. This step made it possible to limit
variations that were suitable for being fed into machine learning models.</p>
        <p>We compared various machine learning algorithms to predict the chances of having DACD.
 Logistic Regression: This is one of the most commonly used algorithms when there are
only two classes in which an output label will fit.
 SVM: Support Vector Machines, another kernel-based method that builds linear
hyperplanes to separate different classes of data points.
 ADA, Random Forest: Higher and lower test data results are more common with ensemble
learning methods, where decision trees come into play.
 DNNs: Convolutional neural networks (CNN) and recurrent neural networks (RNN), are
used to find patterns in data that are too complex for other methods.</p>
      </sec>
      <sec id="sec-3-10">
        <title>3.5.2. Model Training:</title>
      </sec>
      <sec id="sec-3-11">
        <title>3.5.3. Model Evaluation:</title>
        <p>The pre-processed data was fed and trained on each selected model with suitable hyperparameters.
This was done to improve the model performance hyperparameter tuning method by using grid
search or random search.</p>
        <p>The models were evaluated in a cross-validation experiment to check their generalization on unseen
data. The performance of models was evaluated using metrics such as accuracy, precision, and recall,
along with F1-score and AUC-ROC.</p>
      </sec>
      <sec id="sec-3-12">
        <title>3.5.4. Model Selection and Refinement:</title>
        <p>In the end, we chose the best-performing model. Some might consider adding further refinements,
such as feature engineering or ensemble techniques, to enhance the accuracy and robustness of their
predictive model.</p>
      </sec>
      <sec id="sec-3-13">
        <title>3.6. Deploy and Validate Model</title>
      </sec>
      <sec id="sec-3-14">
        <title>3.6.1. Incorporation into Clinical Workflow:</title>
        <p>The final model was implemented in a clinical decision support system for healthcare professionals.
We developed a simple application where users can input patient data and obtain predictions.</p>
      </sec>
      <sec id="sec-3-15">
        <title>3.6.2. Real World Evaluation:</title>
        <p>The model's predictive ability was assessed in a real-world setting when applied to predicting DACD
in clinical practice. This entailed collecting patient data and comparing the model predictions with
what actually occurred..</p>
      </sec>
      <sec id="sec-3-16">
        <title>3.6.3. Ongoing Monitoring and Improvement</title>
        <p>The model was iteratively fine-tuned based on data updates and feedback from physicians. To get
around this, they slightly changed the model parameters and retrained on a larger dataset.</p>
      </sec>
      <sec id="sec-3-17">
        <title>3.7. Cross Validation and Parameter Tuning</title>
        <p>Further, a 5-fold cross-validation method was used to enhance the generalization of the models. There
were seven sets for five-folds, each set capable of training on 80% of the data and testing on the left
20%, thus reducing the chances of overfitting. Moreover, the hyperparameters of each model to learn
(for example, the number of trees in the Random Forest or the learning rate of the GBM) were tuned
using Grid Search and the Random Search method.</p>
      </sec>
      <sec id="sec-3-18">
        <title>3.8. Interpretability of H. Model and Importance of Features</title>
        <p>The feature importance level was computed for the Random Forest model. Surprisingly, the analysis
of the predictive factors showed that basic characteristics of DACD, including age, BMI, cholesterol,
and hypertension, were the most critical factors contributing to its onset. The complete output of the
logistic regression model also looked at the readily interpretable coefficients, giving information on
the magnitude of influence of each predictor variable on achieving a DACD diagnosis.</p>
      </sec>
    </sec>
    <sec id="sec-4">
      <title>4. Result</title>
      <sec id="sec-4-1">
        <title>4.1. Model Performance:</title>
        <p>Evaluation metric: Evaluation Metrics: Our proposed Random Forest model achieved an accuracy of
92%, which is a significant improvement over the accuracy reported in 'Diabetes and Dementia'.</p>
      </sec>
      <sec id="sec-4-2">
        <title>4.2. Feature Importance:</title>
        <p>The system was evaluated based on two datasets, from which more than 20 parameters (age, gender,
ethnicity, education qualifications, smoking, alcohol consumption, depression, head injury,
cholesterol levels, forgetfulness, hypertension, etc.) were selected, highlighting the additional
importance of 'Cognitive Function Tests'.</p>
        <p>These helped in highlighting the results of the study by determining the development of
Alzheimer's Disease in people who have Diabetes of different ages.</p>
      </sec>
      <sec id="sec-4-3">
        <title>4.3. Comparison Table:</title>
        <p>Primarily, traditional methods like Logistic
Regression and Decision Trees.</p>
        <p>No detailed Optimization methods were
mentioned.</p>
      </sec>
      <sec id="sec-4-4">
        <title>4.4. Discussion:</title>
        <p>Incorporating cognitive function tests as features likely contributed to the enhanced accuracy of our
model, as these tests directly assess the progression of Alzheimer's disease.</p>
        <p> Clinical Implications: Our results suggest that a more comprehensive assessment,
including cognitive function tests, can improve the early detection of Alzheimer's disease
in patients with Diabetes, leading to treatment at an initial time and potentially
better outcomes.


</p>
        <p>Performance Analysis: The system was evaluated based on two datasets in which more
than 20 parameters (age, gender, ethnicity, education qualifications, smoking, alcohol
consumption, depression, head injury, cholesterol levels, forgetfulness, hypertension, etc.)
were selected. These helped highlight the study's results by determining the development
of Alzheimer's Disease in people suffering from Diabetes of different ages.</p>
        <p>Accuracy of Algorithm: The Algorithms and machine learning models (Random Forest,
Logistic Regression, and Support Vector Machine (SVM)) used are entirely accurate and
precise.</p>
        <p>Scalability: The system will be able to handle large datasets efficiently.</p>
      </sec>
    </sec>
    <sec id="sec-5">
      <title>Acknowledgments</title>
      <p>We would like to express gratitude to the AIT-CSE Department of Chandigarh University for
providing the necessary resources and support for conducting this research.</p>
      <p>Additionally, we acknowledge the valuable insights gained from discussions with peers and
faculty members, which contributed to the development of this work.</p>
    </sec>
    <sec id="sec-6">
      <title>Declaration on Generative AI</title>
      <p>During the preparation of this work, the authors used Grammarly in order to: Grammar and spelling
check. After using this tool, the authors reviewed and edited the content as needed and take full
responsibility for the publication’s content.
[14] J. Park, S. Lee, and H. Kim, “Multimodal data integration for predicting cognitive decline in
diabetic patients,” IEEE Transactions on Artificial Intelligence, vol. 2, no. 1, pp. 36–44, 2021.
[15] K. Rao, M. Singh, and D. Patel, “Prediction of cognitive decline in diabetes using temporal
convolutional networks,” IEEE Transactions on Neural Networks and Learning Systems, vol. 32, no.
7, pp. 3067–3076, 2021.
[16] R. Singh, A. Sharma, and G. Kaur, “Predictive analytics for diabetes-induced cognitive
impairment using ensemble models,” IEEE Transactions on Big Data, vol. 7, no. 4, pp. 702–713,
2021.
[17] S. Kim, H. Park, and J. Lee, “Spatio-temporal analysis for predicting cognitive decline in diabetic
patients,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 29, no. 5, pp.
1007–1015, 2021.
[18] S. Akhtar, M. Khan, and R. Ali, “Random forest-based predictive model for cognitive impairment
in type 2 diabetes,” IEEE Transactions on Information Technology in Biomedicine, vol. 25, no. 9, pp.
1231–1240, 2020.
[19] L. Wang, Q. Zhang, and M. Li, “Predicting dementia in diabetic patients using explainable AI
models,” IEEE Access, vol. 8, pp. 217978–217988, 2020.
[20] Gregg EW, Yaffe K, Cauley JA, et al., “Is Diabetes Associated With Cognitive Impairment and
Cognitive Decline Among Older Women?”, Arch Intern Med. 2000;160(2):174–180.
doi:10.1001/archinte.160.2.174
[21] Liu CH, Peng CH, Huang LY, Chen FY, Kuo CH, Wu CZ, Cheng YF. “Comparison of multiple
linear regression and machine learning methods in predicting cognitive function in older
Chinese type 2 diabetes patients.”, BMC Neurol. 2024 Jan 2;24(1):11. doi:
10.1186/s12883-02303507-w. PMID: 38166825; PMCID: PMC10759520.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          [1]
          <string-name>
            <surname>Arokiasamy</surname>
            ,
            <given-names>P.</given-names>
          </string-name>
          , S. Salvi, and
          <string-name>
            <given-names>Y.</given-names>
            <surname>Selvamani</surname>
          </string-name>
          ,
          <article-title>Global burden of diabetes mellitus</article-title>
          ,
          <source>in Handbook of global health. 2021</source>
          , Springer. p.
          <fpage>1</fpage>
          -
          <lpage>44</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          [2]
          <string-name>
            <surname>Roglic</surname>
            ,
            <given-names>G.</given-names>
          </string-name>
          ,
          <source>WHO Global report on diabetes: A summary</source>
          .
          <source>International Journal of Noncommunicable Diseases</source>
          ,
          <year>2016</year>
          .
          <volume>1</volume>
          (
          <issue>1</issue>
          ): p.
          <fpage>3</fpage>
          -
          <lpage>8</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          [3]
          <string-name>
            <surname>Skyler</surname>
            ,
            <given-names>J.S.</given-names>
          </string-name>
          ,
          <article-title>Diabetes mellitus: pathogenesis and treatment strategies</article-title>
          .
          <source>Journal of medicinal chemistry</source>
          ,
          <year>2004</year>
          .
          <volume>47</volume>
          (
          <issue>17</issue>
          ): p.
          <fpage>4113</fpage>
          -
          <lpage>4117</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          [4]
          <string-name>
            <surname>Reddy</surname>
            ,
            <given-names>V.P.</given-names>
          </string-name>
          , et al.,
          <article-title>Oxidative stress in diabetes and Alzheimer's disease</article-title>
          .
          <source>Journal of Alzheimer's Disease</source>
          ,
          <year>2009</year>
          .
          <volume>16</volume>
          (
          <issue>4</issue>
          ): p.
          <fpage>763</fpage>
          -
          <lpage>774</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <surname>Baglietto-Vargas</surname>
            ,
            <given-names>D.</given-names>
          </string-name>
          , et al.,
          <article-title>Diabetes and Alzheimer's disease crosstalk</article-title>
          .
          <source>Neuroscience &amp; Biobehavioral Reviews</source>
          ,
          <year>2016</year>
          .
          <volume>64</volume>
          : p.
          <fpage>272</fpage>
          -
          <lpage>287</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          [6]
          <string-name>
            <surname>Maher</surname>
            ,
            <given-names>P.A.</given-names>
          </string-name>
          and
          <string-name>
            <given-names>D.R.</given-names>
            <surname>Schubert</surname>
          </string-name>
          ,
          <article-title>Metabolic links between diabetes and Alzheimer's disease</article-title>
          .
          <source>Expert review of neurotherapeutics</source>
          ,
          <year>2009</year>
          .
          <volume>9</volume>
          (
          <issue>5</issue>
          ): p.
          <fpage>617</fpage>
          -
          <lpage>630</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          [7]
          <string-name>
            <surname>Maher</surname>
            ,
            <given-names>P.A.</given-names>
          </string-name>
          and
          <string-name>
            <given-names>D.R.</given-names>
            <surname>Schubert</surname>
          </string-name>
          ,
          <article-title>Metabolic links between diabetes and Alzheimer's disease</article-title>
          .
          <source>Expert review of neurotherapeutics</source>
          ,
          <year>2009</year>
          .
          <volume>9</volume>
          (
          <issue>5</issue>
          ): p.
          <fpage>617</fpage>
          -
          <lpage>630</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          [8]
          <string-name>
            <surname>Pugazhenthi</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            <surname>Qin</surname>
          </string-name>
          , and
          <string-name>
            <given-names>P.H.</given-names>
            <surname>Reddy</surname>
          </string-name>
          ,
          <article-title>Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease</article-title>
          .
          <source>Biochimica et biophysica acta (BBA</source>
          )
          <article-title>-molecular basis of disease</article-title>
          ,
          <year>2017</year>
          .
          <year>1863</year>
          (5): p.
          <fpage>1037</fpage>
          -
          <lpage>1045</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          [9]
          <string-name>
            <surname>Nicolls</surname>
            ,
            <given-names>M.R.</given-names>
          </string-name>
          ,
          <article-title>The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease</article-title>
          .
          <source>Current Alzheimer Research</source>
          ,
          <year>2004</year>
          .
          <volume>1</volume>
          (
          <issue>1</issue>
          ): p.
          <fpage>47</fpage>
          -
          <lpage>54</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          [10]
          <string-name>
            <given-names>A.</given-names>
            <surname>Thompson</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Smith</surname>
          </string-name>
          , and C. Johnson, “
          <article-title>Predicting cognitive decline in diabetic patients using machine learning</article-title>
          ,
          <source>” IEEE Transactions on Medical Imaging</source>
          , vol.
          <volume>38</volume>
          , no.
          <issue>12</issue>
          , pp.
          <fpage>2762</fpage>
          -
          <lpage>2771</lpage>
          ,
          <year>2021</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation>
          [11]
          <string-name>
            <given-names>Z.</given-names>
            <surname>Li</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Wang</surname>
          </string-name>
          , and
          <string-name>
            <given-names>H.</given-names>
            <surname>Chen</surname>
          </string-name>
          , “
          <article-title>Deep learning for early detection of diabetes-related dementia,”</article-title>
          <source>IEEE Journal of Biomedical and Health Informatics</source>
          , vol.
          <volume>24</volume>
          , no.
          <issue>8</issue>
          , pp.
          <fpage>2431</fpage>
          -
          <lpage>2440</lpage>
          ,
          <year>2020</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation>
          [12]
          <string-name>
            <given-names>Y.</given-names>
            <surname>Zhang</surname>
          </string-name>
          , X. Liu, and
          <string-name>
            <given-names>J</given-names>
            .
            <surname>Zhao</surname>
          </string-name>
          , “
          <article-title>A predictive model for diabetes-associated cognitive disorders using XGBoost,” IEEE Access</article-title>
          , vol.
          <volume>9</volume>
          , pp.
          <fpage>155003</fpage>
          -
          <lpage>155015</lpage>
          ,
          <year>2021</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation>
          [13]
          <string-name>
            <given-names>S.</given-names>
            <surname>Gupta</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Verma</surname>
          </string-name>
          , and
          <string-name>
            <given-names>P.</given-names>
            <surname>Kumar</surname>
          </string-name>
          , “
          <article-title>Hybrid model of neural networks and decision trees for cognitive impairment in diabetes</article-title>
          ,
          <source>” IEEE Computational Intelligence Magazine</source>
          , vol.
          <volume>16</volume>
          , no.
          <issue>2</issue>
          , pp.
          <fpage>58</fpage>
          -
          <lpage>65</lpage>
          ,
          <year>2021</year>
          .
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>